编号 | 药品通用名称 | 英文名称 | 商品名 | 规格 | 剂型 | 持牌商 | 备注1 | 备注2 | 信息来源 | 公布日期 |
---|---|---|---|---|---|---|---|---|---|---|
8-220 |
Alendronate Sodium and Vitamin D3 Tablets |
阿仑膦酸钠(以C4H13NO7P2计)70mg和维生素D3 5600IU |
片剂 |
Merck Sharp & Dohme Ltd./N.V. Organon |
原研进口 |
增加持证商N.V. Organon |
第七十批 |
2023-07-14 |
||
8-7 |
Alendronate Sodium and Vitamin D3 Tablets |
阿仑膦酸钠(以C4H13NO7P2计)70mg和维生素D3 2800IU |
片剂 |
Merck Sharp & Dohme Ltd./N.V. Organon |
原研进口 |
增加持证商N.V. Organon |
第七十批 |
2023-07-14 |
||
63-3 |
Anhydrous Ethanol Injection |
ABLYSINOL |
99%(5ml) |
注射剂 |
BELCHER PHARMACEUTICALS LLC / BPI Labs, LLC |
未进口原研药品 |
增加持证商BPI Labs, LLC |
第七十批 |
2023-07-14 |
|
42-25 |
Fluoxetine Hydrochloride Oral Solution |
PROZAC |
20mg/5ml |
口服液 |
Lilly France/Eli Lilly Italia S.p.A./Eli Lilly Nederland B.V. |
未进口原研药品 |
增加持证商Eli Lilly Nederland B.V. |
第七十批 |
2023-07-14 |
|
39-39 |
Levothyroxine Sodium Tablets |
200μg(以左甲状腺素钠计) |
片剂 |
Merck Serono GmbH/Merck Sante/Merck Gesellschaft mbH/Merck BV |
未进口原研药品 |
增加持证商Merck BV |
第七十批 |
2023-07-14 |
||
30-116 |
Scopolamine Butylbromide Injection |
Buscapina/Buscopan |
1ml:20mg |
注射剂 |
Sanofi-aventis/Sanofi/Aventis/Sanofi S.p.A./Sanofi-Aventis Deutschland GmbH |
未进口原研药品 |
增加持证商Sanofi-Aventis Deutschland GmbH |
第七十批 |
2023-07-14 |
|
27-423 |
Levothyroxine Sodium Tablets |
Euthyrox;Levothyrox |
100μg(以左甲状腺素钠计) |
片剂 |
Merck Serono GmbH/Merck Sante/Merck Gesellschaft mbH/Merck BV |
未进口原研药品 |
增加持证商Merck BV |
第七十批 |
2023-07-14 |
|
27-421 |
Levothyroxine Sodium Tablets |
Euthyrox;Levothyrox |
25μg(以左甲状腺素钠计) |
片剂 |
Merck Serono GmbH/Merck Sante/Merck Gesellschaft mbH/Merck BV |
未进口原研药品 |
增加持证商Merck BV |
第七十批 |
2023-07-14 |
|
26-87 |
Fexofenadine Hydrochloride Oral Suspension |
Children’s Allegra Allergy |
30mg/5ml |
混悬剂 |
Sanofi Aventis US LLC/Chattem Inc Dba Sanofi Consumer Healthcare |
未进口原研药品 |
增加持证商Chattem Inc Dba Sanofi Consumer Healthcare |
第七十批 |
2023-07-14 |
|
26-36 |
Azithromycin Ophthalmic Solution |
Azasite |
0.01 |
滴眼液 |
Oka Pharmaceuticals Inc Subsidary Of Akorn Inc/Thea pharma inc |
未进口原研药品 |
增加持证商Thea pharma inc |
第七十批 |
2023-07-14 |
|
23-197 |
Ezetimibe rosuvastatin calcium film-coated tablet |
依折麦布10mg/瑞舒伐他汀10mg |
片剂 |
Sanofi-Aventis, S.R.O./Sanofi-Aventis Ireland Limited T/A SANOFI |
未进口原研药品 |
增加持证商Sanofi-Aventis Ireland Limited T/A SANOFI |
第七十批 |
2023-07-14 |
||
23-183 |
Tapentadol Hydrochloride Extended Release Tablets |
Nucynta Er |
Eq250mg Base |
缓释片 |
Depo Nf Sub LLC A Sub Of Assertio Therapeutics Inc/Collegium Pharmaceutical Inc |
未进口原研药品 |
增加持证商Collegium Pharmaceutical Inc |
第七十批 |
2023-07-14 |
|
23-182 |
Tapentadol Hydrochloride Extended Release Tablets |
Nucynta Er |
Eq200mg Base |
缓释片 |
Depo Nf Sub LLC A Sub Of Assertio Therapeutics Inc/Collegium Pharmaceutical Inc |
未进口原研药品 |
增加持证商Collegium Pharmaceutical Inc |
第七十批 |
2023-07-14 |
|
23-181 |
Tapentadol Hydrochloride Extended Release Tablets |
Nucynta Er |
Eq150mg Base |
缓释片 |
Depo Nf Sub LLC A Sub Of Assertio Therapeutics Inc/Collegium Pharmaceutical Inc |
未进口原研药品 |
增加持证商Collegium Pharmaceutical Inc |
第七十批 |
2023-07-14 |
|
23-180 |
Tapentadol Hydrochloride Extended Release Tablets |
Nucynta Er |
Eq100mg Base |
缓释片 |
Depo Nf Sub LLC A Sub Of Assertio Therapeutics Inc/Collegium Pharmaceutical Inc |
未进口原研药品 |
增加持证商Collegium Pharmaceutical Inc |
第七十批 |
2023-07-14 |
|
23-179 |
Tapentadol Hydrochloride Extended Release Tablets |
Nucynta Er |
Eq 50mg Base |
缓释片 |
Depo Nf Sub LLC A Sub Of Assertio Therapeutics Inc/Collegium Pharmaceutical Inc |
未进口原研药品 |
增加持证商Collegium Pharmaceutical Inc |
第七十批 |
2023-07-14 |
|
22-444 |
Levalbuterol hydrochloride Inhalation Solution |
XOPENEX |
0.31mg/3ml |
喷雾剂 |
OAK PHARMACEUTICALS INC SUBSIDIARY OF AKORN INC/Akorn |
未进口原研药品 |
增加持证商Akorn |
第七十批 |
2023-07-14 |
|
22-443 |
Levalbuterol hydrochloride Inhalation Solution |
XOPENEX |
0.63mg/3ml |
喷雾剂 |
OAK PHARMACEUTICALS INC SUBSIDIARY OF AKORN INC/Akorn |
未进口原研药品 |
增加持证商Akorn |
第七十批 |
2023-07-14 |
|
8-44 |
Paracetamol Effervescent Tablets/Panadol ActiFast Soluble Tablets |
0.5g |
泡腾片 |
GlaxoSmithKline Consumer Healthcare |
未进口原研药品 |
欧盟上市 |
第七十批 |
2023-07-14 |
||
70-21 |
Sitagliptin Phosphate Tablets |
捷诺维 |
100 mg |
片剂 |
杭州默沙东制药有限公司 |
经审核确定的国外原研企业在中国境内生产的药品 |
原研地产化 |
第七十批 |
2023-07-14 |